Director, Levine Cardiac Intensive Care Unit
Brigham and Women's Hospital
David A. Morrow, MD, MPH is a Professor of Medicine at Harvard Medical School, and the Section Head for Critical Care Cardiology at Brigham and Women’s Hospital. He a Senior Investigator with the TIMI Study Group, chairman of the Executive Committee for the Critical Care Cardiology Trials Network (CCCTN), Co-chair of the AHA Cardiogenic Shock Registry and a member of the leadership council for the ACC Section on Critical Care Cardiology.
Disclosure(s): 4TEEN4: Grant/Research Support (Ongoing); Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Ongoing); Anthos Therapeutics: Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Daiichi Sankyo: Grant/Research Support (Ongoing); Merck & Co.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Regeneron Pharmaceuticals Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Roche Diagnostics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
PATHOPHYSIOLOGY OF CARDIOGENIC SHOCK LV AND RV
Sunday, March 8, 2026
8:00 AM - 9:25 AM EST
Insights into Cardiogenic Shock from the Critical Care Cardiology Network
Sunday, March 8, 2026
8:32 AM - 8:40 AM EST
Sunday, March 8, 2026
9:04 AM - 9:25 AM EST
Update on the AHA Cardiogenic Shock Registry
Sunday, March 8, 2026
11:17 AM - 11:25 AM EST
Sunday, March 8, 2026
11:41 AM - 12:05 PM EST